1. Home
  2. TOP vs HROW Comparison

TOP vs HROW Comparison

Compare TOP & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOP Financial Group Limited

TOP

TOP Financial Group Limited

SELL

Current Price

$15.62

Market Cap

1.9B

Sector

Finance

ML Signal

SELL

HROW

Harrow Inc.

BUY

Current Price

$30.79

Market Cap

1.7B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TOP
HROW
Founded
2015
1998
Country
Singapore
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
TOP
HROW
Price
$15.62
$30.79
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $65.00
AVG Volume (30 Days)
86.9K
★ 534.4K
Earning Date
07-07-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.25
71.43
EPS
★ N/A
N/A
Revenue
★ $4,723,765.00
N/A
Revenue This Year
N/A
$28.59
Revenue Next Year
N/A
$53.17
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 41.89
N/A
52 Week Low
$0.61
$28.54
52 Week High
$17.42
$54.98

Technical Indicators

Market Signals
Indicator
TOP
HROW
Relative Strength Index (RSI) 61.16 29.69
Support Level $14.44 $28.54
Resistance Level $16.20 $35.43
Average True Range (ATR) 0.80 1.26
MACD -0.18 -0.11
Stochastic Oscillator 64.85 18.71

Price Performance

Historical Comparison
TOP
HROW

About TOP TOP Financial Group Limited

TOP Financial Group Ltd is operates as an online brokerage firm in Hong Kong specializing in the trading of local and overseas equities, futures, and options products. It conduct the futures and stock brokerage business through three trading platforms, Esunny for futures trading and Longbridge for stock trading, all of which were licensed from third parties and can be easily accessed through its application, or APP, software, and websites. The three platforms are designed for seamless, efficient, and secure trading platform. The company operates and manages its business as a single operating and reportable segment.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: